1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved.
(
- Contribution to journal › Article
- 2013
-
Mark
The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
(
- Contribution to journal › Article
- 2011
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
(
- Contribution to journal › Article
- 2009
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article
- 2008
-
Mark
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments
(
- Contribution to journal › Article
-
Mark
The burden of ankylosing spondylitis in Spain.
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: determinants of access
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: health burden and costs
(
- Contribution to journal › Article
-
Mark
Patient access to rheumatoid arthritis treatments
(
- Contribution to journal › Debate/Note/Editorial